Skip to main content Help with accessibility Skip to main navigation

BROLUCIZUMAB injection (Beovu®▼) for diabetic macular oedema

CCG Approval Status:

Date Added: 29 - Sep - 2022
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of BROLUCIZUMAB injection (Beovu®▼), by specialists only, for diabetic macular oedema in accordance with NICE TA820.

NHS Cheshire and Merseyside APPROVED